A Space for Teens with Cancer

Video

Teen Cancer America partners with hospitals throughout the United States to develop specialized facilities and services for teens and young adults with cancer. We build teen friendly environments, develop standards for age-targeted care, improve collaboration between pediatric and adult specialists, and support dedicated research to improve outcomes and survival rates.

Recent Videos
image of a woman in front of a blue background with a navy top
woman with a white top sitting in front of a green wall
a man wearing a suit and tie in front of a green screen with the ONN logo
a woman sitting in front of a green wall with a white top and glasses
Related Content
Blue diagram of a person's torso with the gastrointestinal tract highlighted in orange

Trastuzumab Combo Shows Numerical Survival Benefit in Gastric/GEJ Cancer

Russ Conroy
January 29th 2025
Article

The addition of trastuzumab and pertuzumab to chemotherapy was associated with increased toxicity in patients with HER2-positive gastric cancers enrolled in the INNOVATION trial.

The Vitals

What New Cancer Drugs Were Approved in 2023?

Lindsay Fischer
January 1st 2024
Podcast

In this special episode of The Vitals, we ring in the New Year 2024 by combing through 2023 FDA approvals.

light green background with blue text indicating FDA and dark green text saying approved with a check mark

FDA Approves T-DXd for Previously Treated HER2-Low and -Ultralow Metastatic Breast Cancer

Ashling Wahner
Published: January 27th 2025 | Updated: January 28th 2025
Article

T-DXd has received FDA approval for the treatment of unresectable or metastatic HR+, HER2-low/-ultralow breast cancer in patients whose disease progressed on prior endocrine therapy in the metastatic setting.

The Vitals

Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

Lindsay Fischer
December 14th 2023
Podcast

Beth Finley-Oliver, MSN, ARNP, AGNP-BC, recaps part of her presentation from the 2023 JADPRO meeting about caring for patients with high-risk multiple myeloma.

Diagram of a person with gastrointestinal tract highlighted

Evorpacept Demonstrates Efficacy in HER2-Positive Gastric/GEJ Cancer

Roman Fabbricatore
January 27th 2025
Article

Phase 2 findings show clinical responses and improved survival with evorpacept in patients with HER2-positive gastric/gastroesophageal cancer.

illustration of the gastrointestinal tract with people in lab coats around the drawing

ctDNA Status May Be Prognostic for DFS With Celecoxib for Stage III Resected Colon Cancer

Ashling Wahner
January 26th 2025
Article

While ctDNA positivity was linked to worse overall disease-free survival (DFS) in stage III resected colon cancer, it was associated with significantly improved DFS with celecoxib compared to placebo.